152 related articles for article (PubMed ID: 1647064)
1. Modulation of platelet aggregation by an L-arginine-nitric oxide pathway.
Radomski MW; Palmer RM; Moncada S
Trends Pharmacol Sci; 1991 Mar; 12(3):87-8. PubMed ID: 1647064
[No Abstract] [Full Text] [Related]
2. [Platelet aggregation in modulation of the pathway L-arginine-NO in rats with cerebral ischemia].
Maksimovich NE
Patol Fiziol Eksp Ter; 2005; (4):14-5. PubMed ID: 16408659
[TBL] [Abstract][Full Text] [Related]
3. Dietary L-arginine supplementation normalizes platelet aggregation in hypercholesterolemic humans.
Wolf A; Zalpour C; Theilmeier G; Wang BY; Ma A; Anderson B; Tsao PS; Cooke JP
J Am Coll Cardiol; 1997 Mar; 29(3):479-85. PubMed ID: 9060881
[TBL] [Abstract][Full Text] [Related]
4. Oral L-arginine inhibits platelet aggregation but does not enhance endothelium-dependent dilation in healthy young men.
Adams MR; Forsyth CJ; Jessup W; Robinson J; Celermajer DS
J Am Coll Cardiol; 1995 Oct; 26(4):1054-61. PubMed ID: 7560599
[TBL] [Abstract][Full Text] [Related]
5. Effect of L-arginine load on platelet aggregation: a comparison between normotensive and preeclamptic pregnant women.
Facchinetti F; Neri I; Piccinini F; Marietta M; Torelli U; Bruschettini PL; Volpe A
Acta Obstet Gynecol Scand; 1999 Jul; 78(6):515-9. PubMed ID: 10376861
[TBL] [Abstract][Full Text] [Related]
6. L-arginine infusion decreases platelet aggregation through an intraplatelet nitric oxide release.
Marietta M; Facchinetti F; Neri I; Piccinini F; Volpe A; Torelli G
Thromb Res; 1997 Oct; 88(2):229-35. PubMed ID: 9361375
[TBL] [Abstract][Full Text] [Related]
7. Characterization of the L-arginine:nitric oxide pathway in human platelets.
Radomski MW; Palmer RM; Moncada S
Br J Pharmacol; 1990 Oct; 101(2):325-8. PubMed ID: 1701676
[TBL] [Abstract][Full Text] [Related]
8. Endogenous nitric oxide protects against platelet aggregation and cyclic flow variations in stenosed and endothelium-injured arteries.
Yao SK; Ober JC; Krishnaswami A; Ferguson JJ; Anderson HV; Golino P; Buja LM; Willerson JT
Circulation; 1992 Oct; 86(4):1302-9. PubMed ID: 1394936
[TBL] [Abstract][Full Text] [Related]
9. Investigation of the existence and biological role of L-arginine/nitric oxide pathway in human platelets by spin-trapping/EPR studies.
Prónai L; Ichimori K; Nozaki H; Nakazawa H; Okino H; Carmichael AJ; Arroyo CM
Eur J Biochem; 1991 Dec; 202(3):923-30. PubMed ID: 1662618
[TBL] [Abstract][Full Text] [Related]
10. The effect of endothelium-derived nitric oxide on ex vivo whole blood platelet aggregation in man.
Vallance P; Benjamin N; Collier J
Eur J Clin Pharmacol; 1992; 42(1):37-41. PubMed ID: 1541315
[TBL] [Abstract][Full Text] [Related]
11. Inhibitory effects of endogenous L-arginine analogues on nitric oxide synthesis in platelets: role in platelet hyperaggregability in hypertension.
de Meirelles LR; Mendes-Ribeiro AC; Santoro MM; Mendes MA; da Silva MN; Mann GE; Brunini TM
Clin Exp Pharmacol Physiol; 2007 Dec; 34(12):1267-71. PubMed ID: 17973865
[TBL] [Abstract][Full Text] [Related]
12. Biosynthesis and actions of nitric oxide.
Moncada S; Palmer RM
Semin Perinatol; 1991 Feb; 15(1):16-9. PubMed ID: 2063225
[No Abstract] [Full Text] [Related]
13. Cultured astrocytoma cells generate a nitric oxide-like factor from endogenous L-arginine and glyceryl trinitrate: effect of E. coli lipopolysaccharide.
Salvemini D; Mollace V; Pistelli A; Anggård E; Vane J
Br J Pharmacol; 1992 Aug; 106(4):931-6. PubMed ID: 1327394
[TBL] [Abstract][Full Text] [Related]
14. Nitric oxide synthase inhibition and platelet function.
Bodzenta-Lukaszyk A; Gabryelewicz A; Lukaszyk A; Bielawiec M; Konturek JW; Domschke W
Thromb Res; 1994 Sep; 75(6):667-72. PubMed ID: 7530387
[No Abstract] [Full Text] [Related]
15. Effects of nutritional status on the L-arginine-nitric oxide pathway in platelets from hemodialysis patients.
da Silva CD; Brunini TM; Reis PF; Moss MB; Santos SF; Roberts NB; Ellory JC; Mann GE; Mendes-Ribeiro AC
Kidney Int; 2005 Nov; 68(5):2173-9. PubMed ID: 16221216
[TBL] [Abstract][Full Text] [Related]
16. L-arginine modulates aggregation and intracellular cyclic 3,5-guanosine monophosphate levels in human platelets: direct effect and interplay with antioxidative thiol agent.
Anfossi G; Russo I; Massucco P; Mattiello L; Perna P; Tassone F; Trovati M
Thromb Res; 1999 Jun; 94(5):307-16. PubMed ID: 10379819
[TBL] [Abstract][Full Text] [Related]
17. Impairment of the L-arginine-nitric oxide pathway in mast cells from spontaneously hypertensive rats.
Masini E; Mannaioni PF; Pistelli A; Salvemini D; Vane J
Biochem Biophys Res Commun; 1991 Jun; 177(3):1178-82. PubMed ID: 1711845
[TBL] [Abstract][Full Text] [Related]
18. Cloned murine T lymphocytes synthesize a molecule with the biological characteristics of nitric oxide.
Kirk SJ; Regan MC; Barbul A
Biochem Biophys Res Commun; 1990 Dec; 173(2):660-5. PubMed ID: 2175602
[TBL] [Abstract][Full Text] [Related]
19. Effects of nebivolol on human platelet aggregation.
Falciani M; Rinaldi B; D'Agostino B; Mazzeo F; Rossi S; Nobili B; Rossi F; Filippelli A
J Cardiovasc Pharmacol; 2001 Dec; 38(6):922-9. PubMed ID: 11707696
[TBL] [Abstract][Full Text] [Related]
20. Human colorectal adenocarcinoma cells: differential nitric oxide synthesis determines their ability to aggregate platelets.
Radomski MW; Jenkins DC; Holmes L; Moncada S
Cancer Res; 1991 Nov; 51(22):6073-8. PubMed ID: 1718593
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
